Four faces of cellular senescence
Open accessThe DOI matches its Crossref record; 133 of the 137 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.
Abstract
Cellular senescence is an important mechanism for preventing the proliferation of potential cancer cells. Recently, however, it has become apparent that this process entails more than a simple cessation of cell growth. In addition to suppressing tumorigenesis, cellular senescence might also promote tissue repair and fuel inflammation associated with aging and cancer progression. Thus, cellular senescence might participate in four complex biological processes (tumor suppression, tumor promotion, aging, and tissue repair), some of which have apparently opposing effects. The challenge now is to understand the senescence response well enough to harness its benefits while suppressing its drawbacks.
Overview
CoChat Summary
## TL;DR
Cellular senescence is presented as an essentially irreversible growth arrest that suppresses tumor formation, but the paper argues it also has broader roles in tumor promotion, aging, and tissue repair. The authors frame these effects as arising from the senescence-associated secretory phenotype (SASP) and from the context in which senescent cells accumulate.
## Key findings
- Senescence is described as a crucial anticancer mechanism: in human and mouse premalignant lesions, senescent cells are abundant, but they are “markedly diminished” in the malignant tumors that develop from those lesions.
- Senescent cells can promote tumor progression in mouse xenografts: co-injection of senescent fibroblasts with premalignant epithelial cells enabled malignant cancer formation, and co-injection with fully malignant cells “markedly accelerates” tumor formation.
- Senescent cells may contribute to aging and degeneration: transgenic mice with chronically elevated p53 activity showed “shortened life span and premature aging,” including loss of fertility, osteoporosis, sarcopenia, dermal thinning, loss of subcutaneous fat, reduced hair growth, and retarded wound healing.
- In tissue repair, senescence appears beneficial: after acute liver injury, stellate cells undergo senescence, ECM production declines, MMP secretion increases, and mice impaired for senescence because of p53 or p16INK4a/p19ARF deficiencies developed “severe fibrosis” after injury.
## Methods
- This is a narrative review synthesizing prior studies across human tissues, mouse models, cell culture, and mouse xenografts.
- The paper compares senescent versus nonsenescent cells and summarizes experimental perturbations of p53, p16INK4a/pRB, Pten, Klotho, BubR1, p63, and CCN1 in relation to senescence phenotypes.
- Main analysis is interpretive and mechanistic: the authors connect published findings to a model in which senescence has temporally ordered phases, including early growth arrest, SASP induction, and later immune clearance or tissue-level effects.
## Limitations
- The paper itself states that evidence for senescence driving aging is “circumstantial,” and that cause-and-effect cannot yet be tested cleanly because organisms lacking senescence generally die prematurely of cancer.
- It also notes that there are “no definitive answers” for how senescence might promote late-life cancer.
- Evident from the text: many claims rely on mouse models, cell culture, and xenografts rather than direct demonstration in naturally occurring human disease.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 1 Not valid · 8 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“thus p53 can be pro-aging or pro-longevity, depending on the physiological context (de Keizer et al., 2010).”
§ Four faces of cellular senescence > Cellular senescence and aging > Altered p53 function and aging.
What the sources say
- Supportedcites de Keizer et al., 2010 source
The paper states directly that p53 can be either pro-aging or pro-longevity depending on physiological context. It also explains that p53 can promote or retard aging depending on how its activity is regulated. (LLM, conf=0.95)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low-level, chronic, “sterile” inflammation is a hallmark of aging that initiates or promotes most, if not all, major age-related diseases (Franceschi et al., 2007; Chung et al., 2009).”
§ Four faces of cellular senescence > Cellular senescence and aging > How might senescent cells promote age-related pathologies?
What the sources say
- Not checked — no full text of the sourcecites Franceschi et al., 2007 source
- Partly supportedcites Chung et al., 2009 sourceExperimental — accuracy not yet measured
The Introduction describes chronic, low-grade inflammation as a possible link between aging and the pathogenesis of many age-related diseases; the Conclusion calls it a primary factor underlying aging and numerous age-related diseases. The copy does not characterize the inflammation as “sterile,” and its references to many or numerous diseases do not substantiate “most, if not all.” Page numbers were not available in the indexed passages. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which comprise a negative feedback loop to dampen NF-κB activity (Taganov et al., 2006; Freund et al., 2010).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion (page not specified in our copy) proposes that NF-κB induces miR-146 genes, which could reduce IRAK1 and TRAF6 levels and thereby dampen pathway activity. The claim presents that proposed negative-feedback effect as established; the paper says further studies are needed to determine miR-146’s exact role. (LLM, conf=0.85)
- Supportedcites Freund et al., 2010 source
The “Chromatin organization” section states that miR-146a/b provide negative feedback that inhibits NF-κB activity. The “microRNAs” section likewise describes them as part of an NF-κB feedback loop. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Whatever the case, the examples above, and a growing list of similar studies (Collado and Serrano, 2010), argue that cellular senescence restrains cancer by imposing a cell-autonomous block to the proliferation of oncogenically damaged/stressed cells (Fig. 2).”
§ Four faces of cellular senescence > Cellular senescence and tumor suppression
What the sources say
- Supportedcites Collado and Serrano, 2010 source
The Introduction (page not provided) describes oncogenically stressed cells stopping division through a cell-cycle arrest and identifies oncogene-induced senescence as a tumour-suppressor mechanism. The Preface adds that senescence stably blocks proliferation and that progression to malignancy requires evading it. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The induction of these miRNAs may prevent the SASP from generating persistent acute (robust) inflammation, which, unlike low-level chronic inflammation, is designed to be self-limiting (Taganov et al., 2006).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion proposes that induced miR-146 could dampen inflammatory signaling through a negative-feedback loop. It does not address the SASP or establish that these miRNAs prevent it from generating persistent acute inflammation; nor does it make the stated comparison with low-level chronic inflammation. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
30 more claims · 2 with their cited sources checked
Create a free account to see all 45 claims and every source verdict.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased numbers of senescent cells with age are an important contributor to the age-associated increase in inflammation because senescent cells secrete a large number of pro-inflammatory proteins (senescence-associated secretory phenotype, or SASP) (Rodier and Campisi, 2011).”
From The Aging Epigenome (2016) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence can be triggered by multiple mechanisms, including those resulting in ROS production and oxidative stress (Kuilman et al., 2010; Rodier and Campisi, 2011).”
From mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis (2012) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cells undergoing damage-induced senescence are often cleared by the immune system, as several SASP factors are cytokines and chemokines that can modulate the local immune environment.2,3,5,70,71”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which exhibit various senescence-related phenotypes, like increased size of nucleoli, enlarged and overloaded lysosome, and secretion of senescence-associated secretory phenotype (SASP) factors.5,6,7”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent findings have uncovered an additional beneficial effect of the senescence response and accompanying SASP: the ability to promote optimal repair of damaged tissue (59, 91, 145–147).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [147]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 2×
“Moreover, to form a lethal tumor, cancer cells must acquire a greatly expanded growth potential and ability to proliferate while expressing activated oncogenes (Hanahan and Weinberg, 2000), traits that are suppressed by the senescence program.”
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“First, senescent cells increase with age in a variety of mammalian tissues (Dimri et al., 1995; Paradis et al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007; Wang et al., 2009).”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“…al., 1991; Shay et al., 1991; Bond et al., 1994; Lin et al., 1998; Schmitt et al., 2002; Beauséjour et al., 2003; Collins and Sedivy, 2003; Oren, 2003; Herbig et al., 2004; Jacobs and de Lange, 2004; Ohtani et al., 2004; Chen et al., 2005; Campisi and d’Adda di Fagagna, 2007; Rodier et al., 2007).”
Self-citationTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Cited by
Items 1,101–1,200 of 2,013
HCSGD: An integrated database of human cellular senescence genes
Dong, Q., Han, H., Liu, X., Wei, L., Zhang, W., Zhao, Z., Zhang, M. Q., & Wang, X. (2017) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.04.001 · Cited by 24
Yamada, K., Doi, S., Nakashima, A., Kawaoka, K., Ueno, T., Doi, T., Yokoyama, Y., Arihiro, K., Kohno, N., & Masaki, T. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1070-2 · Cited by 20
“cytokines [26], increased numbers of senescent cells in the kidney can be detrimental in the long term.”
BackgroundHuang, Z., Xu, P., Hess, D. C., & Zhang, Q. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00457-2 · Cited by 20
Morera, L., Roatsch, M., Fürst, M. C. D., et al. (2016) · ChemMedChem · doi:10.1002/cmdc.201600218 · Cited by 19
Quantitative Analysis of Cellular Senescence in Culture and In Vivo
Zhao, J., Fuhrmann‐Stroissnigg, H., Gurkar, A. U., Flores, R. R., Dorronsoro, A., Stolz, D. B., Croix, C. M. S., Niedernhofer, L. J., & Robbins, P. D. (2017) · Current Protocols in Cytometry · doi:10.1002/cpcy.16 · Cited by 22
Determinants of Frailty and Longevity: Are They the Same Ones?
Rodríguez‐Mañas, L. (2015) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000382057 · Cited by 22
Schwensow, N., Detering, H., Pederson, S., Mazzoni, C. J., Sinclair, R. G., Peacock, D. E., Kovaliski, J., Cooke, B. D., Fickel, J., & Sommer, S. (2017) · Molecular Ecology · doi:10.1111/mec.14228 · Cited by 19
Moringa oleifera (Lam.): a natural remedy for ageing?
Athira Nair, D., James, T. J., Sreelatha, S., Kariyil, B. J., & Nair, S. (2020) · Natural Product Research · doi:10.1080/14786419.2020.1837815 · Cited by 21
“Moreover, p16 also regulates apoptosis which also makes the situation more complicated (Rodier and Campisi 2011).”
BackgroundPourrajab, F., Zarch, A. V., Hekmatimoghaddam, S., & Zare‐Khormizi, M. R. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.05.004 · Cited by 20
Senescence in RASopathies, a possible novel contributor to a complex pathophenoype
Engler, M., Fidan, M., Nandi, S., & Cirstea, I. C. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111411 · Cited by 16
“…2020 Mechanisms of Ageing and Development 194 (2021) 111411 studies expanded further the broad impact of senescence in organismal homeostasis by identifying a fundamental contribution to embryonic development and tissue repair (Adams, 2009; Da Silva-Álvarez et al., 2019; Rodier and Campisi, 2011).”
BackgroundStress-induced cellular senescence contributes to chronic inflammation and cancer progression.
KOBASHIGAWA, S., M. SAKAGUCHI, Y., MASUNAGA, S., & MORI, E. (2019) · Thermal Medicine · doi:10.3191/thermalmed.35.41 · Cited by 18
Suboptimal extracellular pH values alter DNA damage response to induced double‐strand breaks
Massonneau, J., Ouellet, C., Lucien, F., Dubois, C. M., Tyler, J. K., & Boissonneault, G. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12384 · Cited by 17
Erikson, D. W., Barragan, F., Piltonen, T., Chen, J. C., Balayan, S., Irwin, J. C., & Giudice, L. C. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox092 · Cited by 19
“While the transcriptome of the PeriM eSF in the current study does not wholly represent that of a senescent cell population, the downregulation of organismal death pathways (Table 2), increased matrix metalloproteinase (MMP) expression (Table 1), and increased EGFR expression (Table 1) are all common with senescent or…”
BackgroundInfluentialWang, C., Kang, Y., Liu, P., Liu, W., Chen, W., Hayashi, T., Mizuno, K., Hattori, S., Fujisaki, H., & Ikejima, T. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114260 · Cited by 18
Calado, R. T. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00008-6 · Cited by 20
“suppressors.(34) However, short telomeres increase the percentage of senes-”
Background2,2′‐Bipyridine‐Modified Tamoxifen: A Versatile Vector for Molybdacarboranes
Schwarze, B., Jelača, S., Welcke, L., Maksimović‐Ivanić, D., Mijatović, S., & Hey‐Hawkins, E. (2019) · ChemMedChem · doi:10.1002/cmdc.201900554 · Cited by 18
Kwon, J. H., Kim, M., Um, S., Lee, H. J., Bae, Y. K., Choi, S. J., Hwang, H. H., Oh, W., & Jin, H. J. (2021) · Cells · doi:10.3390/cells10010063 · Cited by 25
“For example, most cellular stress that causes senescence activates DNA damage response (DDR) kinases including Ataxia Telangiectasia mutated (ATM) and Ataxia Telangiectasia and Rad3 related (ATR), which regulate p53 and p16 primarily through proteasomal and epigenetic regulation [18,19].”
BackgroundPreventing clonal evolutionary processes in cancer: Insights from mathematical models
Rodriguez-Brenes, I. A., & Wodarz, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501730112 · Cited by 22
“There is also evidence that senescent cells contribute to a host of age-related degenerative pathologies (25).”
BackgroundComisford, R., Lubbers, E. R., Householder, L. A., Suer, O., Tchkonia, T., Kirkland, J. L., List, E. O., Kopchick, J. J., & Berryman, D. E. (2015) · Gerontology · doi:10.1159/000439050 · Cited by 19
George, B., Horn, D., Bayo, P., Zaoui, K., Flechtenmacher, C., Grabe, N., Plinkert, P. K., Krizhanovsky, V., & Heß, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.042 · Cited by 23
“Interestingly, etoposide-treated FaDu cells showed a gradual decrease in MYBBP1A protein levels, while p21CDKN1A as a marker of early cellular senescence [30] was strongly induced (Fig.”
BackgroundA large-scale CRISPR screen and identification of essential genes in cellular senescence bypass
Liu, X., Wei, L., Dong, Q., Liu, L., Zhang, M. Q., Xie, Z., & Wang, X. (2019) · Aging · doi:10.18632/aging.102034 · Cited by 21
“Cellular senescence acts as an important tumor-suppression mechanism, but in the meanwhile, its dark sides may lead to inflammation, tumor promotion, or aging [2].”
BackgroundChen, S.-Y., Zhao, J., Shi, B., Xu, C., & Zhao, S. (2021) · Chemical Communications · doi:10.1039/d1cc00455g · Cited by 17
Ma, Y., Li, S., Ye, S., Hu, D., Wei, L. J., & Xiao, F. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113645 · Cited by 18
Rapamycin‑induced miR‑30a downregulation inhibits senescence of VSMCs by targeting Beclin1
Tan, P., Wang, H., Zhan, J., Ma, X., Cui, X., Wang, Y., Wáng, Y., Zhong, J., & Liu, Y. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4074 · Cited by 20
“Senescence, which is thought to be irreversible, is considered to contribute to alteration in cell function, morphology, and gene expression (2), and thus has an important role in diseases, including type 2 diabetes, cancer, neurodegeneration, and age-associated cardiovascular diseases, such as atherosclerosis (3).”
BackgroundWang, S., Heng, K., Song, X., Zhai, J., Zhang, H., & Geng, Q. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300330 · Cited by 19
Herb-Derived Products: Natural Tools to Delay and Counteract Stem Cell Senescence
Abruzzo, P. M., Canaider, S., Pizzuti, V., Pampanella, L., Casadei, R., Facchin, F., & Ventura, C. (2020) · Stem Cells International · doi:10.1155/2020/8827038 · Cited by 20
Sharma, S., & Bhonde, R. R. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24789 · Cited by 20
“It has been reported that senescence can either lead to cancer progression or cancer suppression or aging or tissue repair (Rodier and Campisi, 2011).”
BackgroundMizutani, T., Ishizaka, A., & Furuichi, Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657155 · Cited by 20
“There has been increasing evidence concerning an active cross-talk between senescent and neighboring cells via secretory factors such as growth factors, extracellular proteases, cytokines, and chemokines (19).”
BackgroundAge-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases
Eugenín, J. L., Bernhardi, L. E.-V., & Rommy von Bernhardi, M. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1249320 · Cited by 20
“…arrest, increased cell size, and several characteristics that involve a secretory profile called senescent associated secretory phenotype (SAPS) (Rodier and Campisi, 2011), the presence of DNA damage or “scars,” changes in heterochromatin called Senescence-Associated Heterochromatin Foci (SAHF)…”
Gunaratna, R. T., Santos, A., Luo, L., Nagi, C. S., Lambertz, I. U., Spier, M. E., Conti, C. J., & Fuchs‐Young, R. (2019) · Oncogene · doi:10.1038/s41388-018-0630-4 · Cited by 18
Mandl, M., Wagner, S., Hatzmann, F. M., Ejaz, A., Ritthammer, H., Baumgarten, S., Viertler, H. P., Springer, J., Zwierzina, M., Mattesich, M., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa098 · Cited by 18
“Since IL-6 is a frequent component of SASPs and its levels were relatively high in both CRISPR-construct #1 and CRISPR-GFP ASCs, IL-6 was also examined by qRT-PCR analysis and ELISA.”
BackgroundInfluentialProstate Cancer Induced by Loss of Apc Is Restrained by TGFβ Signaling
Bjerke, G. A., Pietrzak, K., Melhuish, T. A., Frierson, H. F., Paschal, B. M., & Wotton, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092800 · Cited by 17
“A senescent phenotype can be induced in tumors either by activation of an oncogene, or by inactivation of a tumor suppressor gene [51].”
BackgroundJeong, S., & Cho, G. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3191 · Cited by 18
“Previous studies have shown that the accumulating senescent cells caused by a loss of tissue homeostasis(2,22) induce a functional decline in those and surrounding cells.(23,24) Deursen et al.”
BackgroundToward a Molecular Classification of Colorectal Cancer: The Role of Telomere Length
Baichoo, E., & Boardman, L. A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00158 · Cited by 22
“Thus as stromal cells undergo senescence, they exhibit a secretory phenotype that may trigger neighboring cells with shortened telomeres to by-pass the senescence signal and termination, setting the stage for chromosomal instability and malignant transformation (13).”
BackgroundHepatocyte senescence induced by radiation and partial hepatectomy in rat liver
Serra, M. P., Marongiu, F., Sini, M., Marongiu, M. E., Contini, A., Wolff, H. A., Rave‐Fränk, M., Krause, P., Laconi, E., & Koenig, S. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.922714 · Cited by 17
“Cell senescence was initially interpreted as a fail-safe mechanism to avoid the risk of neoplastic transformation in cells harboring damaged DNA (Rodier and Campisi 2011).”
BackgroundSun, J. P., Tian, T., Wang, Y., Yan, W., Zhang, B., Wang, K., Yang, H., & Huang, M. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105076 · Cited by 17
Baisantry, A., Berkenkamp, B., Rong, S., Bhayadia, R., Sörensen-Zender, I., Schmitt, R., & Melk, A. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00333.2018 · Cited by 18
“The development of cellular senescence after acute stress is thought to be a gradual process in which p53 and p21 are among several signals that promote the senescent phenotype through temporally regulated steps (25).”
Backgroundp19INK4d is involved in the cellular senescence mechanism contributing to heterochromatin formation
Sonzogni, S. V., Ogara, M. F., Belluscio, L. M., Castillo, D., Scassa, M. É., & Cánepa, E. T. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.03.015 · Cited by 18
Molecular turnover, the H3.3 dilemma and organismal aging (hypothesis)
Saade, E., Pirozhkova, I., Aimbetov, R., Lipinski, M., & Ogryzko, V. V. (2015) · Aging Cell · doi:10.1111/acel.12332 · Cited by 23
“…secretory phenotype (SASP), which results in the secretion of various growth factors, cytokines, and proteases (called summarily senescence messaging secretome (SMS) (Kuilman & Peeper, 2009)), leading to agerelated tissue dysfunction and disruption (Coppe et al., 2008; Rodier & Campisi, 2011).”
BackgroundHuang, Y., Li, S., Ye, W., Wang, H., Su, J., Gao, L., Shi, R., Mou, X., Leng, S. X., Xiao, C., et al. (2025) · Vaccines · doi:10.3390/vaccines13040431 · Cited by 22
“[56,89].”
Shao, Q., Esseltine, J. L., Huang, T., Novielli‐Kuntz, N. M., Ching, J. E., Sampson, J. B., & Laird, D. W. (2019) · Biomolecules · doi:10.3390/biom9090474 · Cited by 17
“Compared to control MSCs, Cx43-/- cells exhibited characteristics of cells that are beginning to senesce [42,43].”
BackgroundKishi, S., Bayliss, P. E., & Hanai, J. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.007 · Cited by 18
Sapega, O., Mikyškov�, R., Bieblov�, J., Mrázková, B., Hodn�, Z., & Reiniš, M. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4553 · Cited by 21
Methodology Advances in Vertebrate Age Estimation
Zhang, Y., Bi, J., Ning, Y., & Feng, J. (2024) · Animals · doi:10.3390/ani14020343 · Cited by 22
Biological Aging Marker p16INK4a in T Cells and Breast Cancer Risk
Shen, J., Song, R., Fuemmeler, B. F., McGuire, K. P., Chow, W., & Zhao, H. (2020) · Cancers · doi:10.3390/cancers12113122 · Cited by 20
Promoter hypermethylation of cysteine dioxygenase type 1 in patients with non‑small cell lung cancer
Yin, W., Wang, X., Li, Y., Wang, B., Song, M., Hulbert, A., Chen, C., & Yu, F. (2020) · Oncology Letters · doi:10.3892/ol.2020.11592 · Cited by 17
“Lung cancer is an age-associated disease (28-30) and alterations in DNA methylation may be due to the harmful effects exerted by tobacco smoking (31).”
Genes and pathways involved in senescence bypass identified by functional genetic screens
Roupakia, E., Markopoulos, G. S., & Kolettas, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111432 · Cited by 19
The Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis
Valenzuela, C. A., Quintanilla, R., Moore‐Carrasco, R., & Brown, N. E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00188 · Cited by 18
Yang, C., Qiao, W., Xue, Q., Goltzman, D., Miao, D., & Zhan, D. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.08.012 · Cited by 25
“These findings suggest that the senolytic activity of ABT263 may not only eliminate the detrimental effects of senescent cells but also mitigate the oxidative stress and genomic instability associated with cellular senescence [40].”
BackgroundTargeting Dermal Fibroblast Senescence: From Cellular Plasticity to Anti-Aging Therapies
Jipu, R., Șerban, I. L., Goriuc, A., Jipu, A. G., Luchian, I. A., Amititeloaie, C., Tărniceriu, C. C., Hurjui, I., Butnaru, O., & Hurjui, L. L. (2025) · Biomedicines · doi:10.3390/biomedicines13081927 · Cited by 24
“Senescent cells enter a state of permanent cessation, exhibiting characteristics such as resistance to apoptosis, morphological changes, and the secretion of pro-inflammatory factors (senescence-associated secretory phenotype or SASP) [3].”
Morales-Rosales, S. L., Santín-Márquez, R., Posadas-Rodriguez, P., Rincon-Heredia, R., Montiel, T., Librado-Osorio, R., Luna-López, A., Rivero-Segura, N. A., Torres, C., Cano-Martínez, A., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.766306 · Cited by 17
“In addition, senescent cells, through the senescence-associated secretory phenotype (SASP), secrete a complex mixture of factors, including proinflammatory cytokines and tissue remodelers, that may adversely affect neighboring cells and tissues with chronic inflammatory signals and oxidative stress (Rodier and Campisi…”
BackgroundPark, A.-M., Tsunoda, I., & Yoshie, O. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003310 · Cited by 23
“The production of various SASP factors is considered to be beneficial for the host by promoting immune clearance of damaged cells and preventing proliferation of potential cancer cells (45, 46).”
BackgroundHuman Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions
Chmielewski, P. P., Data, K., Strzelec, B., Farzaneh, M., Anbiyaiee, A., Zaheer, U., Uddin, S., Sheykhi-Sabzehpoush, M., Mozdziak, P. E., Zabel, M., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0280 · Cited by 34
The Muller’s Ratchet and Aging
Govindaraju, D. R., Innan, H., & Veitia, R. A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.02.004 · Cited by 18
Tokumoto, Y., Tamaki, S., Kabe, Y., Takubo, K., & Suematsu, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01023-9 · Cited by 16
Kettner, N. M., Bui, T. N., Navarro-Yepes, J., Ghotbaldini, S., Quintela, B., Luo, C. K., Lam, N., Rao, X., Raghavendra, A. S., Wang, Y., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01041-1 · Cited by 23
Hansen, J. L., Carroll, J., Seeman, T. E., Cole, S. W., & Rentscher, K. E. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.022 · Cited by 25
“(Campisi and D ’ Adda Di Fagagna, 2007; Kirkland and Tchkonia, 2017; Maggiorani et al., 2017; Rodier and Campisi, 2011) Senescent cells exhibit increased expression of the intracellular protein and cell cycle inhibitor p16 INK4a .”
Whole chromosome aneuploidy in the brain of Bub1bH/Hand Ercc1−/Δ7mice
Andriani, G. A., Faggioli, F., Baker, D. J., Dollé, M. E. T., Sellers, R. S., Hébert, J. M., STEEG, H. V., Hoeijmakers, J. H. J., Vijg, J., & Montagna, C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv612 · Cited by 17
“escent cells can also be identified by their lackof proliferation and activation of tumor suppressor networks (37,38); thus, to rule out the possibility that aneuploid cells enter premature senescence, it would be interesting to the follow-up our findings and examine”
BackgroundSuccoio, M., Comegna, M., DˈAmbrosio, C., Scaloni, A., Cimino, F., & Faraonio, R. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.07.010 · Cited by 17
“By producing a chronic senescence-associated secretory phenotype (SASP), senescent cells can also trigger paracrine senescence in neighboring cells, interfere with architecture/function of tissues, and stimulate inflammatory phenotypes paradoxically promoting a pro-oncogenic environment [16,17].”
BackgroundSestrin2 Attenuates Cellular Senescence by Inhibiting NADPH Oxidase 4 Expression
Hwang, C. Y., Han, Y., Lee, S.-M., Cho, S.-M., Yu, D., & Kwon, K. (2020) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.20.0051 · Cited by 18
Metformin attenuates lipopolysaccharide‐induced epithelial cell senescence by activating autophagy
Wang, Y., Chen, H., Sun, C., Shen, H., & Cui, X. (2020) · Cell Biology International · doi:10.1002/cbin.11536 · Cited by 21
“Cell senescence is regarded as the response to stress originating from various sources, including telomere erosion and other DNA damage, mitochondrial dysfunction, and others (Rodier & Campisi, 2011).”
BackgroundRestoration of Mesenchymal RPE by Transcription Factor-Mediated Reprogramming
Shih, Y.-H., Radeke, M. J., Radeke, C. M., & Coffey, P. J. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20018 · Cited by 15
Lee, H., Massaro, M., Abdelfattah, N., Baudo, G., Liu, H., Yun, K., & Blanco, E. (2024) · Aging Cell · doi:10.1111/acel.14446 · Cited by 19
“through increased secretion of senescence-associated secretory phenotype (SASP) factors consisting of cytokines and growth factors that contribute to inflammation through effects such as immune cell re - cruitment (Rodier & Campisi, 2011 ).”
Functional relevance of miRNAs in premature ageing
Caravia, X. M., Roiz‐Valle, D., Morán-Álvarez, A., & López-Otín, C. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.05.003 · Cited by 17
“However, the progressive accumulation of senescent cells is an ageing-promoting mechanism and contributes to the modulation of organismal lifespan (Rodier and Campisi, 2011).”
BackgroundTakayama, K., Kawakami, Y., Lee, S., Greco, N., Lavasani, M., Mifune, Y., Cummins, J. H., Yurube, T., Kuroda, R., Kurosaka, M., et al. (2014) · Journal of Orthopaedic Research® · doi:10.1002/jor.22656 · Cited by 17
NK Cell Senescence in Cancer: From Molecular Mechanisms to Therapeutic Opportunities
Qiu, Z., Li, Z., Zhang, C., Zhao, Q., Liu, Z., Cheng, Q., Zhang, J., Lin, A., & Luo, P. (2025) · Aging and Disease · doi:10.14336/ad.2025.0053 · Cited by 26
“Similarly, various cytokines and chemokines modulate NK cell development and function, enabling these cells to perform distinct immunosurveillance roles across different tissues [10].”
InfluentialAdipose-Derived Stem Cells Respond to Increased Osmolarities
Potočar, U., Hudoklin, S., Kreft, M. E., Završnik, J., Božikov, K., & Fröhlich, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163870 · Cited by 18
Targets of Immune Regeneration in Rheumatoid Arthritis
Hohensinner, P. J., Goronzy, J. J., & Weyand, C. M. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.01.020 · Cited by 18
Ageing and cancer: a research gap to fill
Solary, É., Abou‐Zeid, N., & Calvo, F. M. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13222 · Cited by 19
Replicative Senescence and Expression of Autophagy Genes in Mesenchymal Stromal Cells
Ratushnyy, A. Y., Rudimova, Y. V., & Buravkova, L. B. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920100053 · Cited by 17
Nieh, Y., Chou, Y., Chou, Y., Wang, C., Lin, S., Ciou, S., Yuh, C., & Wang, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147883 · Cited by 18
“Many stimuli conduct cellular senescence including telomere shortening, DNA damage and oxidative stress [27].”
BackgroundPotential of Hibiscus sabdariffa L. and Hibiscus Acid to Reverse Skin Aging
Wang, D., Nagata, M., Matsumoto, M., Amen, Y. M., Wang, D., & Shimizu, K. (2022) · Molecules · doi:10.3390/molecules27186076 · Cited by 26
Ebrahimirad, F., Mirmahdizade, S. E., Mahmoodieh, B., Najafi, S., Banihashemian, S. A., Nikakhtar, S., Mobaraki, H., Sadeghi, A., Kossari, N., SadatRafiei, S. K., et al. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1543360 · Cited by 21
“The SASP includes various transcription factors, growth factors, proin fl ammatory cytokines, including Interleukin (IL)-1, IL-6 , and IL-8 , proteases, and matrix metalloproteinases (Rodier and Campisi, 2011).”
Lorentzen, J. A., Grzyb, K., Angelis, P. M. D., Hoff, G. S., Eide, T. J., & Andresen, P. A. (2016) · Clinical Medicine Insights Pathology · doi:10.4137/cpath.s40143 · Cited by 18
Characterization of Induction and Targeting of Senescent Mesenchymal Stromal Cells
Gresham, R. C. H., Kumar, D., Copp, J., Lee, M., & Leach, J. K. (2022) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2022.0048 · Cited by 19
“13 We observed increased expression of p16 in replicative induced senescent groups at the earliest time point compared with all other groups (Fig.”
Homologous recombination-mediated irreversible genome damage underlies telomere-induced senescence
Ghadaouia, S., Olivier, M., Martinez, A., Kientega, T., Jian, Q., Lambert-Lanteigne, P., Cardin, G. B., Autexier, C., Malaquin, N., & Rodier, F. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab965 · Cited by 19
Self-citationFeunteun, J., Ostyn, P., & Delaloge, S. (2022) · iScience · doi:10.1016/j.isci.2022.104217 · Cited by 18
“The first evidence for pro-tumorigenic effects of cellular senescence was provided by the demonstration that senescent fibroblasts promote epithelial cell growth and tumorigenesis (Krtolica et al., 2001; Rodier and Campisi, 2011).”
BackgroundCheng, Y., Chiang, H.-Y., Cheng, S.-J., Chang, H.-W., Li, Y., & Shieh, S.-Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03248-5 · Cited by 19
Kaiser, B., Böttner, M., Wedel, T., Brunner, R. M., Goldammer, T., Lesko, S., Gäbel, G., Gleich, A., & Pfannkuche, H. (2017) · Cells Tissues Organs · doi:10.1159/000453394 · Cited by 15
“Nevertheless, the use of primary cultures is limited by small proliferative life spans that precede permanent growth arrest, termed “in vitro cellular senescence” [Hayflick, 1965, 1985; Kuilman et al., 2010; Rodier and Campisi, 2011].”
BackgroundArlia‐Ciommo, A., Leonov, A., Mohammad, K., Beach, A., Richard, V. R., Bourque, S. D., Burstein, M. T., Goldberg, A. A., Kyryakov, P., Gomez-Perez, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26188 · Cited by 14
Marcozzi, S., Rossi, V., Salvatore, G., Rella, F. D., Felici, M. D., & Klinger, F. G. (2019) · Aging · doi:10.18632/aging.102476 · Cited by 16
“SASP includes the secretion of numerous pro-inflammatory cytokines, chemokines, growth factors, and proteases that can have powerful either beneficial or deleterious paracrine activities depending on the physiological environment [36, 37].”
BackgroundQi, L., & Zhang, Y. (2013) · Tumor Biology · doi:10.1007/s13277-013-1410-y · Cited by 16
PEA15 Regulates the DNA Damage-Induced Cell Cycle Checkpoint and Oncogene-Directed Transformation
Nagarajan, A. G., Dogra, S. K., Liu, A. Y., Green, M. R., & Wajapeyee, N. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01542-13 · Cited by 15
“Several mechanisms of oncogene-induced senescence have been proposed (3).”
BackgroundLiu, Y., Schwam, J., & Chen, Q. (2022) · Cells · doi:10.3390/cells11071089 · Cited by 20
“SHH paracrine treatment of OACs activated catabolic signaling in chondrocytes including suppressing anabolic ECM COL2A1 and increasing catabolic MMP13.”
BackgroundFrancica, P., Aebersold, D. M., & Medová, M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.022 · Cited by 15
“The inability of senescent cells to progress through the cell cycle is further accompanied by the acquisition of typical changes in cell morphology such as increase in volume, flat shape, vacuole-rich cytoplasm and increased senescence-associated b-galactosidase (SA-bGal) activity [4,6,7].”
p21 facilitates chronic lung inflammation via epithelial and endothelial cells
Levi, N., Papismadov, N., Majewska, J., Roitman, L., Wigoda, N., Eilam, R., Tsoory, M., Rotkopf, R., Ovadya, Y., Akiva, H., et al. (2023) · Aging · doi:10.18632/aging.204622 · Cited by 15
“The senescence growth arrest is established and maintained by the p53-p21 and p16-Rb pathways [27, 46–48].”
Senescence program and its reprogramming in pancreatic premalignancy
Yang, K., Li, X., & Xie, K. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06040-3 · Cited by 21
“OIS is that the induction of senescence by oncogene activation leads to the withdrawal of cells from the cell cycle and prevents their uncontrolled proliferation [75].”
BackgroundNovel role of the SIRT4-OPA1 axis in mitochondrial quality control
Lang, A., & Piekorz, R. P. (2018) · Cell Stress · doi:10.15698/cst2018.01.118 · Cited by 17
“1 SIRT4 axis was further strengthened by the observation that oligonucleotide mediated inhibition of miR‐15b altered, in a SIRT4-dependent manner, the expression of components of the senescence associated secretory phenotype (SASP; [12]) and nuclear encoded mitochondrial genes, including TFAM (mitochondrial biogenesis…”
BackgroundWu, T., Yang, Z., Chen, W., Jiang, M., Xiao, Z., Su, X., Jiao, Z., Yu, Y., Chen, S., Song, M., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01571-2 · Cited by 19
TAK1 Inhibition Accelerates Cellular Senescence of Retinal Pigment Epithelial Cells
Dvashi, Z., Green, Y. A., & Pollack, A. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14349 · Cited by 15
LEF1 isoforms regulate cellular senescence and aging
Jia, M., Sayed, K., Kapetanaki, M. G., Dion, W. A., Rosas, L., Irfan, S., Valenzi, E., Mora, A. L., Lafyatis, R., Rojas, M. M., et al. (2023) · Aging Cell · doi:10.1111/acel.14024 · Cited by 19
“…hallmarks of aging, is contributing to aging either through the accumulation of damaged senescent cells or the secretion of pro-inflammatory cytokines and matrix metalloproteases, often referred to as senescence associated secretory phenotype (SASP) (Di Micco et al., 2021; Rodier & Campisi, 2011).”
BackgroundChiang, M., Cinquin, A., Paz, A., Meeds, E., Price, C. A., Welling, M., & Cinquin, O. (2015) · BMC Biology · doi:10.1186/s12915-015-0148-y · Cited by 15
Pan, Y., Gu, Z., Lyu, Y., Yang, Y., Chung, M., Pan, X., & Cai, S. (2022) · Rejuvenation Research · doi:10.1089/rej.2022.0021 · Cited by 18
“10,17,18 Senescent cells can produce and secrete a myriad of extracellular modulators that include cytokines ( e.g., interleukin [IL]-1, IL-6), chemokines ( e.g., IL-8, CXCL1, CXCL2), extracellular matrix proteases ( e.g., matrix metalloproteinases [MMPs]), growth factors ( e.g., transforming…”
Cognitive heterogeneity reveals molecular signatures of age-related impairment
Logan, S., Baier, M. P., Owen, D. B., Peasari, J. R., Jones, K. L., Ranjit, R., Yarbrough, H. P., Masingale, A. M., Bhandari, S., Rice, H. C., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad101 · Cited by 22
Graham, Z., Goldberger, A., Azulai, D., Conover, C. F., Ye, F., Bauman, W. A., Cardozo, C. P., & Yarrow, J. F. (2020) · Physiological Reports · doi:10.14814/phy2.14357 · Cited by 13
“The cytokines associated with SASP, such as the early secretion of IL-1α and the later elevations of IL-6 and CXCL1/ GRO, would be expected as they are a characteristic of the development of senescence (Rodier & Campisi, 2011).”
BackgroundYe, C., Cheng, Y. H., Qian, X., Zhong, B., Ma, J., & Guo, H. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10704-w · Cited by 16
“The cancer prevention of cell senescence is due to cell proliferation inhibition and cell cycle arrest (Her-nandez-Segura 2018). p53-p21 cip1 and p16 INK4a -Rb pathways are the main mechanisms of cellular senescence(Rodier, Campisi, and Lawrence Berkeley National Lab.”
Chen, Y., Cai, M., Xu, S. Q., Meng, M., Ren, X., Yang, J. W., Dong, Y.-Q., Liu, X., Yang, J., & Xiong, X.-D. (2016) · Oncotarget · doi:10.18632/oncotarget.10170 · Cited by 15
“Apart from growth arrest, senescent cells often display various characteristic phenotypes including distinct flattened, enlarged, and irregular morphology, increased activity of lysosomal β-galactosidase, robust secretion of inflammatory cytokines [4-7].”
BackgroundEngineered Aging Cardiac Tissue Chip Model for Studying Cardiovascular Disease
Budhathoki, S., Graham, C., Sethu, P., & Kannappan, R. (2021) · Cells Tissues Organs · doi:10.1159/000516954 · Cited by 16
“X at DNA injury sites [Rodier and Campisi, 2011].”
BackgroundLong-term treatment with anti-VEGF does not induce cell aging in primary retinal pigment epithelium
Schottler, J., Randoll, N., Lucius, R., Caliebe, A., Roider, J. B., & Klettner, A. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.03.002 · Cited by 17
“, 1999), alterations in cytokine release (Terzi et al., 2016; Rodier and Campisi, 2011) and alterations in organelle structure and function (Hwang et al.”
BackgroundMao, C.-C., & Cai, X. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x15666200422103916 · Cited by 16
Metadata
- Authors
- Rodier, F., & Campisi, J.
- Affiliations
- The Research Centre of the University of Montreal Hospital Centre/Institut du Cancer de Montréal, Montreal, Quebec, H2L 4M1 Canada 1
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-14
- Volume
- 192
- Issue
- 4
- Pages
- 547-556
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3044123
- OpenAlex
- W2077450385
- Cited by
- 2,070
- References
- 137
- Citations by year
- 2026: 65 · 2025: 94 · 2024: 101 · 2023: 131 · 2022: 113 · 2021: 164 · 2020: 175 · 2019: 154 · 2018: 164 · 2017: 160 · 2016: 162 · 2015: 162 · 2014: 147 · 2013: 126 · 2012: 108
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy
- Cancer Research Society
- Institut Du Cancer de Montréal
- National Institutes of Health
- National Cancer Institute
- Institute of Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, tumor suppression, tumor promotion, aging, tissue repair, inflammation, tumor progression, senescence-associated secretory phenotype, senescence-associated inflammation
- MeSH terms
- Aging, Animals, Humans, Models, Biological, Neoplasms, Wound Healing, Signal Transduction, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.